XML 172 R135.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Financial Statements of Parent Company - Cash Flow (Details) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
OPERATING ACTIVITIES                      
Net income (loss) $ 9,440 $ 2,080 $ 4,089 $ 4,482 $ 7,911 $ 3,867 $ 8,112 $ 11,342     $ 15,047
Equity in undistributed earnings (losses) of subsidiaries                 $ (1,421) $ 2,499 713
Stock-based compensation                 2,913 2,658 2,800
Depreciation and amortization                 3,931 5,003 5,322
Changes in other assets                 (22,045) (6,925) (2,438)
Changes in other liabilities                 267 1,657 (12,426)
Net cash from operating activities                 (285) 58,233 7,353
INVESTING ACTIVITIES                      
Net cash from investing activities                 144,463 88,249 (571,127)
FINANCING ACTIVITIES                      
Common stock options exercised                 1,489 637 2,069
Withholding cash issued in lieu of restricted stock                 (443) (846) (670)
Principal payments on senior term loan                 (6,845) (3,030) (125)
Stock purchase from noncontrolling interest                 0 0 (41)
Cash dividends paid on common stock                 (8,772) (8,639) (8,355)
Net cash from financing activities                 (224,494) 211,467 296,617
Net change in cash and cash equivalents                 (80,316) 357,949 (267,157)
Cash and cash equivalents, beginning of period       398,229       40,280 398,229 40,280 307,437
Cash and cash equivalents, end of period 317,913       398,229       317,913 398,229 40,280
Parent Company                      
OPERATING ACTIVITIES                      
Net income (loss)                 20,091 31,232 15,047
Equity in undistributed earnings (losses) of subsidiaries                 1,702 (31,170) 11,614
Stock-based compensation                 3,330 3,392 3,217
Depreciation and amortization                 305 305 269
Changes in other assets                 (5,118) (11,638) (45,406)
Changes in other liabilities                 (251) (2,887) 16,358
Net cash from operating activities                 20,059 (10,766) 1,099
INVESTING ACTIVITIES                      
Investment in subsidiaries                 (1,550) 150 (240)
Net cash from investing activities                 (1,550) 150 (240)
FINANCING ACTIVITIES                      
Issuance of senior term loan                 0 0 9,877
Common stock options exercised                 1,489 637 2,069
Withholding cash issued in lieu of restricted stock                 (443) (847) (670)
Principal payments on senior term loan                 (6,845) (3,030) (125)
Stock purchase from noncontrolling interest                 0 0 (33)
Cash dividends paid on common stock                 (8,772) (8,639) (8,355)
Net cash from financing activities                 (14,571) (11,879) 2,763
Net change in cash and cash equivalents                 3,938 (22,495) 3,622
Cash and cash equivalents, beginning of period       $ 8,590       $ 31,085 8,590 31,085 27,463
Cash and cash equivalents, end of period $ 12,528       $ 8,590       $ 12,528 $ 8,590 $ 31,085